Other
Daiichi Sankyo soars on $22bn Merck cancer drugs deal
Shares in Japan's Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.
Oct 20, 2023
0
1
Sorted by liverank
Other
EU clears Pfizer's $43 bn takeover of biotech firm Seagen
The EU said Thursday it had given the green light for US pharmaceutical giant Pfizer's $43-billion acquisition of biotech firm Seagen, specializing in innovative cancer treatment.
Oct 19, 2023
0
0
Other
COVID-19 vaccine mandates have come and mostly gone in the US—an ethicist discusses the implications
Ending pandemics is a social decision, not scientific. Governments and organizations rely on social, cultural and political considerations to decide when to officially declare the end of a pandemic. Ideally, leaders try to ...
Oct 18, 2023
0
0
Other
Study sheds light on critical areas for improvement in the delivery of palliative care, particularly among rural nurses
A study published in Collegian has shed light on critical areas for improvement in the delivery of palliative care, particularly among rural nurses.
Oct 18, 2023
0
0
Other
Slowing vaccine demand to weigh on BioNTech profits
German vaccine-maker BioNTech said Monday its earnings would take a hit as demand for its coronavirus jab slowed.
Oct 16, 2023
0
0
Other
US pharmacy chain Rite Aid files for bankruptcy
US pharmacy chain Rite Aid filed for bankruptcy Sunday, the company said, after suffering declining sales and legal threats over its alleged involvement in the opioid crisis.
Oct 16, 2023
0
1
Other
Pfizer cuts earnings outlook on lower COVID-19 drug sales
The US pharmaceutical giant Pfizer sharply scaled back its earnings outlook for the year, blaming lower-than-expected sales of two drugs used to treat COVID-19, the company said Friday.
Oct 14, 2023
0
1
Other
Q&A: Sounding the alarm about disposable plastic in the health care industry
To Jodi Sherman's way of thinking, the Hippocratic Oath's vow of doing no harm includes doing no harm to the planet—particularly when it comes to the sea of single-use plastic flooding the health care industry.
Oct 11, 2023
0
8
Other
Misogyny in medicine impacts us all
Over the last week or so, there has been widespread condemnation of a letter to the editor penned by a retired British anesthetist and published in a U.K. newspaper.
Oct 9, 2023
0
9
Other
US drugmaker Bristol Myers Squibb buys Mirati for $4.8bn
US pharmaceutical company Bristol Myers Squibb announced a $4.8 billion deal on Sunday to acquire cancer drugmaker Mirati Therapeutics.
Oct 9, 2023
0
1
